Biofrontera AG

Biofrontera AG
Stock Exchange Xetra Stock Exchange
EPS
EUR0.19
Market Cap
EUR342.95 M
Shares Outstanding
44.6 M
Public Float
25.58 M

Profile

Address
Hemmelrather Weg 201
Leverkusen Nordrhein-Westfalen 51377
Germany
Employees -
Website http://biofrontera.com
Updated 07/08/2019
Biofrontera AG is a biopharmaceutical company, which engages in the development, sale, and distribution of dermatological drugs and medical cosmetics for the care, protection, and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria, and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

Financials

View All

Ulrich Granzer
Chairman-Supervisory Board
Reinhard Eyring
Member-Supervisory Board